Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$1.04
+2.0%
$0.00
$0.91
$6.50
$19.19MN/A930,070 shs1.17 million shs
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$7.32
+0.3%
$5.80
$3.80
$26.70
$31.78M-0.8426,071 shs11,999 shs
Centogene stock logo
CNTG
Centogene
$0.17
$0.25
$1.53
$8.80M-0.67150,868 shs8.36 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.35
+0.7%
$1.09
$0.40
$1.68
$20.11M4.7419,758 shs6,356 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
-5.56%-45.45%-75.54%+101,999,900.00%+101,999,900.00%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
+5.73%-5.31%+23.04%+42.49%+12.78%
Centogene stock logo
CNTG
Centogene
0.00%0.00%0.00%0.00%-60.63%
Marpai, Inc. stock logo
MRAI
Marpai
+0.37%+3.08%+34.00%+48.89%+48.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.3629 of 5 stars
0.05.00.00.02.11.70.6
Centogene stock logo
CNTG
Centogene
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00
N/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.00
N/AN/AN/A
Centogene stock logo
CNTG
Centogene
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$10.05M1.91N/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$383.96M0.08N/AN/A$56.67 per share0.13
Centogene stock logo
CNTG
Centogene
$48.54M0.00N/AN/A($1.01) per share0.00
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.58N/AN/A($1.72) per share-0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/A0.00N/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$41.93MN/A0.00N/AN/AN/AN/AN/A
Centogene stock logo
CNTG
Centogene
-$38.58MN/A0.00N/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Centogene stock logo
CNTG
Centogene
N/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.15
0.47
0.46
Centogene stock logo
CNTG
Centogene
N/A
1.02
0.96
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82

Institutional Ownership

CompanyInstitutional Ownership
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Centogene stock logo
CNTG
Centogene
9.94%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%

Insider Ownership

CompanyInsider Ownership
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Centogene stock logo
CNTG
Centogene
1.93%
Marpai, Inc. stock logo
MRAI
Marpai
61.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
3618.46 millionN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
9704.34 million2.32 millionNot Optionable
Centogene stock logo
CNTG
Centogene
81027.08 millionN/ANot Optionable
Marpai, Inc. stock logo
MRAI
Marpai
15014.90 million5.61 millionNo Data

Recent News About These Companies

Marpai appoints new COO to accelerate growth
Market Access RICI Agriculture UCITS (MRAI)
Marpai, Inc. (MRAI) Q4 2024 Earnings Call Transcript
MARPAI ANNOUNCES GENERAL UPDATES FOR Q4
Marpai, Inc. Reports Q3 2024 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Basel Medical Group stock logo

Basel Medical Group NASDAQ:BMGL

$1.04 +0.02 (+1.96%)
As of 04:00 PM Eastern

OUR MISSION Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our mission encompasses the four following commitments: Patient–Centered Care. We prioritize our patient’s wellbeing above all else. Innovation. We strive for excellence through innovation and expertise. Global Accessibility. We believe that quality healthcare should be universally available. Continuous Improvement. We constantly improve our services to meet evolving patient needs. With over 20 years of medical services experience, Basel Medical’s journey began with a simple commitment – to restore healthy and active lifestyles, one at a time. Today, that commitment has transformed into a vision for innovation, growth and far-reaching impact. We rely on an experienced group of medical practitioners to provide a wide spectrum of general and subspecialized orthopedic, trauma, sports medicine and neurosurgical services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, minimally invasive orthopedic procedures and other complex neurosurgical procedures. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical (together with its subsidiaries, the “Group”), comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities. Our Group has a patient-oriented philosophy of providing personalized, quality and integrated medical care. We aim to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. Within the next 12 to 18 months, we intend to actively seek acquisition and collaboration partners in Singapore and Malaysia. Our acquisition and collaboration targets include general practitioner (GP) clinics and specialist clinics that complement our orthopedic services, particularly those focused on the musculoskeletal system, aging treatments, physiotherapy and occupational therapists. Our goal is to become an internationally known medical services provider in the Southeast Asian market, with a presence in at least four Southeast Asia countries (potentially covering Singapore, Malaysia, Indonesia and Thailand) within the next three years. As of the date of this prospectus, we have not identified such targets. Basel Medical was incorporated in the BVI on August 10, 2023 with registered number 2129740 as a BVI business company with liability limited by shares. Our BVI registered office is located at Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands VG1110. Our principal executive offices are located in Singapore at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore. Our agent for service of process in the United States is Puglisi & Associates at 850 Library Avenue, Suite 204, Newark, Delaware.

Concord Medical Services stock logo

Concord Medical Services NYSE:CCM

$7.32 +0.02 (+0.27%)
Closing price 03:59 PM Eastern
Extended Trading
$7.28 -0.04 (-0.61%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Centogene stock logo

Centogene NASDAQ:CNTG

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options. The company also offers target and drug screening, clinical development, and market access and expansion, as well as CENTOGENE Biodatabank licenses and insight reports. In addition, it provides early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services, such as whole exome sequencing, whole genome sequencing, and multiomic testing solutions to physicians, laboratories, and hospitals directly or through distributors. The company was founded in 2006 and is headquartered in Rostock, Germany.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.35 +0.01 (+0.75%)
As of 02:38 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.